vs

Side-by-side financial comparison of Turning Point Brands, Inc. (TPB) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $121.0M, roughly 1.8× Turning Point Brands, Inc.). Turning Point Brands, Inc. runs the higher net margin — 6.8% vs 5.8%, a 1.0% gap on every dollar of revenue. On growth, Turning Point Brands, Inc. posted the faster year-over-year revenue change (29.2% vs 9.6%). Turning Point Brands, Inc. produced more free cash flow last quarter ($21.5M vs $-19.2M). Over the past eight quarters, Turning Point Brands, Inc.'s revenue compounded faster (20.7% CAGR vs 9.5%).

Turning Point Australia (TPAUS) is a conservative lobby group based in Australia, affiliated with Turning Point USA but independent of it. Founded by Joel Jammal and first registered in 2023, the group has become active in trying to influence the outcome of the 2026 South Australian state election in March 2026.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

TPB vs UTI — Head-to-Head

Bigger by revenue
UTI
UTI
1.8× larger
UTI
$220.8M
$121.0M
TPB
Growing faster (revenue YoY)
TPB
TPB
+19.6% gap
TPB
29.2%
9.6%
UTI
Higher net margin
TPB
TPB
1.0% more per $
TPB
6.8%
5.8%
UTI
More free cash flow
TPB
TPB
$40.7M more FCF
TPB
$21.5M
$-19.2M
UTI
Faster 2-yr revenue CAGR
TPB
TPB
Annualised
TPB
20.7%
9.5%
UTI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
TPB
TPB
UTI
UTI
Revenue
$121.0M
$220.8M
Net Profit
$8.2M
$12.8M
Gross Margin
55.9%
Operating Margin
16.5%
7.1%
Net Margin
6.8%
5.8%
Revenue YoY
29.2%
9.6%
Net Profit YoY
239.8%
-42.1%
EPS (diluted)
$0.40
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TPB
TPB
UTI
UTI
Q4 25
$121.0M
$220.8M
Q3 25
$119.0M
$222.4M
Q2 25
$116.6M
$204.3M
Q1 25
$106.4M
$207.4M
Q4 24
$93.7M
$201.4M
Q3 24
$90.7M
$196.4M
Q2 24
$93.2M
$177.5M
Q1 24
$83.1M
$184.2M
Net Profit
TPB
TPB
UTI
UTI
Q4 25
$8.2M
$12.8M
Q3 25
$21.1M
$18.8M
Q2 25
$14.5M
$10.7M
Q1 25
$14.4M
$11.4M
Q4 24
$2.4M
$22.2M
Q3 24
$12.4M
$18.8M
Q2 24
$13.0M
$5.0M
Q1 24
$12.0M
$7.8M
Gross Margin
TPB
TPB
UTI
UTI
Q4 25
55.9%
Q3 25
59.2%
Q2 25
57.1%
Q1 25
56.0%
Q4 24
56.0%
Q3 24
55.6%
Q2 24
54.1%
Q1 24
58.2%
Operating Margin
TPB
TPB
UTI
UTI
Q4 25
16.5%
7.1%
Q3 25
21.8%
11.2%
Q2 25
22.6%
6.9%
Q1 25
21.8%
8.1%
Q4 24
19.1%
13.6%
Q3 24
22.9%
13.3%
Q2 24
24.5%
4.2%
Q1 24
23.2%
6.1%
Net Margin
TPB
TPB
UTI
UTI
Q4 25
6.8%
5.8%
Q3 25
17.7%
8.4%
Q2 25
12.4%
5.2%
Q1 25
13.5%
5.5%
Q4 24
2.6%
11.0%
Q3 24
13.6%
9.6%
Q2 24
14.0%
2.8%
Q1 24
14.5%
4.2%
EPS (diluted)
TPB
TPB
UTI
UTI
Q4 25
$0.40
$0.23
Q3 25
$1.13
$0.33
Q2 25
$0.79
$0.19
Q1 25
$0.79
$0.21
Q4 24
$0.15
$0.40
Q3 24
$0.68
$0.35
Q2 24
$0.68
$0.09
Q1 24
$0.63
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TPB
TPB
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$222.8M
$162.8M
Total DebtLower is stronger
$101.4M
Stockholders' EquityBook value
$372.0M
$335.9M
Total Assets
$763.8M
$834.0M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TPB
TPB
UTI
UTI
Q4 25
$222.8M
$162.8M
Q3 25
$201.2M
$169.1M
Q2 25
$109.9M
$70.7M
Q1 25
$99.6M
$96.0M
Q4 24
$48.9M
$172.0M
Q3 24
$33.6M
$161.9M
Q2 24
$142.2M
$115.5M
Q1 24
$130.9M
$116.1M
Total Debt
TPB
TPB
UTI
UTI
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Q1 24
$141.9M
Stockholders' Equity
TPB
TPB
UTI
UTI
Q4 25
$372.0M
$335.9M
Q3 25
$358.2M
$328.1M
Q2 25
$224.8M
$306.8M
Q1 25
$203.4M
$293.9M
Q4 24
$190.4M
$280.0M
Q3 24
$185.7M
$260.2M
Q2 24
$172.8M
$239.4M
Q1 24
$160.0M
$232.6M
Total Assets
TPB
TPB
UTI
UTI
Q4 25
$763.8M
$834.0M
Q3 25
$742.8M
$826.1M
Q2 25
$595.8M
$740.8M
Q1 25
$564.6M
$720.4M
Q4 24
$493.4M
$753.8M
Q3 24
$488.0M
$744.6M
Q2 24
$591.6M
$706.0M
Q1 24
$586.3M
$702.1M
Debt / Equity
TPB
TPB
UTI
UTI
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×
Q1 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TPB
TPB
UTI
UTI
Operating Cash FlowLast quarter
$24.9M
$3.1M
Free Cash FlowOCF − Capex
$21.5M
$-19.2M
FCF MarginFCF / Revenue
17.8%
-8.7%
Capex IntensityCapex / Revenue
2.8%
10.1%
Cash ConversionOCF / Net Profit
3.03×
0.24×
TTM Free Cash FlowTrailing 4 quarters
$43.8M
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TPB
TPB
UTI
UTI
Q4 25
$24.9M
$3.1M
Q3 25
$3.3M
$57.1M
Q2 25
$11.8M
$18.1M
Q1 25
$17.4M
$-789.0K
Q4 24
$17.7M
$23.0M
Q3 24
$13.2M
$67.5M
Q2 24
$13.4M
$10.0M
Q1 24
$22.6M
$-2.5M
Free Cash Flow
TPB
TPB
UTI
UTI
Q4 25
$21.5M
$-19.2M
Q3 25
$-721.0K
$40.6M
Q2 25
$7.8M
$6.8M
Q1 25
$15.2M
$-11.7M
Q4 24
$16.6M
$19.6M
Q3 24
$12.6M
$60.0M
Q2 24
$10.9M
$3.0M
Q1 24
$22.3M
$-8.4M
FCF Margin
TPB
TPB
UTI
UTI
Q4 25
17.8%
-8.7%
Q3 25
-0.6%
18.3%
Q2 25
6.7%
3.4%
Q1 25
14.3%
-5.7%
Q4 24
17.8%
9.7%
Q3 24
13.9%
30.6%
Q2 24
11.7%
1.7%
Q1 24
26.8%
-4.6%
Capex Intensity
TPB
TPB
UTI
UTI
Q4 25
2.8%
10.1%
Q3 25
3.4%
7.4%
Q2 25
3.4%
5.5%
Q1 25
2.1%
5.3%
Q4 24
1.2%
1.7%
Q3 24
0.7%
3.8%
Q2 24
2.7%
4.0%
Q1 24
0.4%
3.2%
Cash Conversion
TPB
TPB
UTI
UTI
Q4 25
3.03×
0.24×
Q3 25
0.16×
3.04×
Q2 25
0.82×
1.69×
Q1 25
1.21×
-0.07×
Q4 24
7.34×
1.04×
Q3 24
1.07×
3.58×
Q2 24
1.03×
2.01×
Q1 24
1.89×
-0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TPB
TPB

US$111.5M92%
Non Us$9.6M8%

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons